XML 43 R31.htm IDEA: XBRL DOCUMENT
v3.25.1

Stock-Based and Other Long-Term Incentive Compensation (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract] |
Schedule of Stock Based Compensation Expense | The following table summarizes the total stock-based compensation expense recognized during the periods presented:
| Three months ended March 31,
| 2025 |  | 2024
Equity-classified | $ | 359 |  |  | $ | 274 |
Liability-classified (1) | — |  |  | — |
| $ | 359 |  |  | $ | 274 |
(1) Represents compensation expense associated with awards that may be settled in cash at the option of the grantee including a nominal amount (less than $1 thousand) during the 2025 period and none during the 2024 period.
Schedule of Option Activity | A summary of all option activity during the three months ended March 31, 2025 is presented below:
| Number of Shares Underlying Stock Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life (years) |  | Aggregate Intrinsic Value
Outstanding, December 31, 2024 | 113,751 |  |  | $ | 20.44 |  |  | 5.84 |  | $ | 747 |
Granted | 40,250 |  |  | $ | 22.19 |  |  |  |  | $ | — |
Exercised | — |  |  | $ | — |  |  |  |  | $ | — |
Canceled/Forfeited | (2,833) |  |  | $ | 21.57 |  |  |  |  | $ | 16 |
Expired | — |  |  | $ | — |  |  |  |  | $ | — |
Outstanding, March 31, 2025 | 151,168 |  |  | $ | 20.89 |  |  | 6.69 |  | $ | 344 |
Exercisable, March 31, 2025 | 64,921 |  |  | $ | 19.98 |  |  | 3.08 |  | $ | 261 |
Schedule of Stock Options Outstanding | The following table summarizes information about our stock options outstanding as of March 31, 2025:
Range of Exercise Prices: | Options Outstanding |  | Options Exercisable
Shares |  | Weighted Average Remaining Contractual Life (years) |  | Weighted Average Exercise Price |  | Shares |  | Weighted Average Exercise Price
$0.01-$18.00 | 29,501 |  |  | 6.99 |  | $ | 10.72 |  |  | 22,835 |  |  | $ | 10.68 |
$18.01-$26.00 | 5,000 |  |  | 9.38 |  | $ | 19.50 |  |  | 1,169 |  |  | $ | 19.65 |
$26.01-$30.00 | 116,667 |  |  | 6.49 |  | $ | 23.51 |  |  | 40,917 |  |  | $ | 25.18 |
| 151,168 |  |  | 6.69 |  | $ | 20.89 |  |  | 64,921 |  |  | $ | 19.98 |
Schedule of Status of Unvested Stock Options | The following table summarizes changes in our unvested stock options during the three months ended March 31, 2025:
| Shares |  | Weighted Average Grant Date Fair Value Per Share
Unvested, December 31, 2024 | 48,998 |  |  | $ | 11.35 |
Granted | 40,250 |  |  | $ | 12.06 |
Vested | (501) |  |  | $ | 10.45 |
Canceled/Forfeited | (2,500) |  |  | $ | 12.46 |
Unvested, March 31, 2025 | 86,247 |  |  | $ | 11.65 |
Schedule of Restricted Stock Activity | The following table summarizes all restricted stock and RSU activity during the three months ended March 31, 2025 is presented below:
| Number of Shares |  | Weighted Average Grant Date Fair Value |  | Weighted Average Remaining Contractual Life (years) |  | Aggregate Intrinsic Value
Outstanding, December 31, 2024 | 131,183 |  |  | $ | 16.39 |  |  | 5.15 |  | $ | 3,516 |
Granted | 55,859 |  |  | $ | 22.19 |  |  |  |  | $ | 1,240 |
Exercised | (22,891) |  |  | $ | 15.46 |  |  |  |  | $ | 580 |
Canceled/Forfeited | — |  |  | $ | — |  |  |  |  | $ | — |
Outstanding, March 31, 2025 | 164,151 |  |  | $ | 18.50 |  |  | 4.81 |  | $ | 3,606 |
| Number of Shares |  | Weighted Average Grant Date Fair Value |  | Weighted Average Remaining Contractual Life (years) |  | Aggregate Intrinsic Value
Outstanding, December 31, 2024 | 15,069 |  |  | $ | 19.51 |  |  | 0.50 |  | $ | 294 |
Granted | — |  |  |  |  |  |  | $ | — |
Vested | — |  |  |  |  |  |  | $ | — |
Canceled/Forfeited | (2,810) |  |  | $ | 19.57 |  |  |  |  | $ | 55 |
Outstanding, March 31, 2025 | 12,259 |  |  | $ | 19.50 |  |  | 0.30 |  | $ | 239 |
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions | The following table summarizes the weighted average grant date fair values of PSUs granted and the assumptions used in the Monte Carlo simulation model for the determination of the grant date fair values of our PSUs granted during the three months ended March 31, 2025:
Weighted-average grant date fair value of PSUs granted | $ | 28.05 |
Risk free rate | 3.93 | %
Expected volatility | 43.9 | %
Expected dividend yield | — | %
Schedule of PSU Activity | The following table summarizes all PSU activity during the three months ended March 31, 2025:
| Number of Shares |  | Weighted Average Grant Date Fair Value |  | Weighted Average Remaining Contractual Life (years) |  | Aggregate Intrinsic Value
Outstanding, December 31, 2024 | 56,764 |  |  | $ | 22.47 |  |  | 2.22 |  | $ | — |
Granted | 39,434 |  |  | $ | 28.05 |  |  |  |  | $ | — |
Vested | — |  |  |  |  |  |  | $ | — |
Canceled/Forfeited | — |  |  |  |  |  |  | $ | — |
Outstanding, March 31, 2025 | 96,198 |  |  | $ | 24.76 |  |  | 2.38 |  | $ | — |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References No definition available. + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration